These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21724722)

  • 1. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.
    Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS
    J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite measures in psoriatic arthritis: GRAPPA 2008.
    Gladman DD; Landewé R; McHugh NJ; Fitzgerald O; Thaci D; Coates L; Mease PJ; Qureshi AA; Krueger GG; Ritchlin CT; Kavanaugh AF; Garg A
    J Rheumatol; 2010 Feb; 37(2):453-61. PubMed ID: 20147481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
    Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
    J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.
    Helliwell PS; FitzGerald O; Fransen J
    J Rheumatol; 2014 Jun; 41(6):1212-7. PubMed ID: 24882854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
    Helliwell PS; Fitzgerald O; Strand CV; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):540-5. PubMed ID: 21362782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus on a core set of domains for psoriatic arthritis.
    Gladman DD; Mease PJ; Strand V; Healy P; Helliwell PS; Fitzgerald O; Gottlieb AB; Krueger GG; Nash P; Ritchlin CT; Taylor W; Adebajo A; Braun J; Cauli A; Carneiro S; Choy E; Dijkmans B; Espinoza L; van der Heijde D; Husni E; Lubrano E; McGonagle D; Qureshi A; Soriano ER; Zochling J
    J Rheumatol; 2007 May; 34(5):1167-70. PubMed ID: 17477480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.
    Healy PJ; Helliwell PS
    Arthritis Rheum; 2008 May; 59(5):686-91. PubMed ID: 18438903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
    Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
    J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus exercise on domains in psoriatic arthritis.
    Gladman DD
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii113-4. PubMed ID: 15708924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
    Helliwell PS; Fitzgerald O; Mease PJ
    J Rheumatol; 2012 Feb; 39(2):398-403. PubMed ID: 22298265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
    Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
    Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting.
    Helliwell PS; Fitzgerald O; Mease PJ; Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2196-7. PubMed ID: 23118286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
    Callis Duffin K; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):562-3. PubMed ID: 21362788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.